Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reflections on the approach to treatment of a mycologic disaster.

Literature DB >> 23384533

Reflections on the approach to treatment of a mycologic disaster.

David A Stevens¹.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 23384533 PMCID： PMC3623368 DOI： 10.1128/AAC.02242-12

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

84 in total

1. Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.

Authors: A Calcagno; L Baietto; F G De Rosa; M C Tettoni; V Libanore; R Bertucci; A D'Avolio; G Di Perri
Journal: J Antimicrob Chemother Date: 2010-10-20 Impact factor: 5.790

2. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors: Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal: N Engl J Med Date: 2007-01-25 Impact factor: 91.245

3. Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum.

Authors: Keith Cássia da Cunha; Deanna A Sutton; Josepa Gené; Javier Capilla; Josep Cano; Josep Guarro
Journal: Antimicrob Agents Chemother Date: 2012-06-25 Impact factor: 5.191

4. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

Authors: D A Stevens; J Y Lee
Journal: Arch Intern Med Date: 1997-09-08

Review 5. Intrathecal amphotericin in the management of coccidioidal meningitis.

Authors: D A Stevens; S A Shatsky
Journal: Semin Respir Infect Date: 2001-12

6. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.

Authors: K N Sorensen; R A Sobel; K V Clemons; D Pappagianis; D A Stevens; P L Williams
Journal: Antimicrob Agents Chemother Date: 2000-06 Impact factor: 5.191

7. A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever.

Authors: Michael Ellis; Roos Bernsen; Hussein Ali-Zadeh; Jörgen Kristensen; Ulla Hedström; Lazaros Poughias; Mark Bresnik; Awad Al-Essa; David A Stevens
Journal: J Med Microbiol Date: 2009-07-09 Impact factor: 2.472

8. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Authors: T J Walsh; J W Hiemenz; N L Seibel; J R Perfect; G Horwith; L Lee; J L Silber; M J DiNubile; A Reboli; E Bow; J Lister; E J Anaissie
Journal: Clin Infect Dis Date: 1998-06 Impact factor: 9.079

9. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.

Authors: Thomas M Kerkering; Marissa L Grifasi; Anthony W Baffoe-Bonnie; Ekta Bansal; Dorothy C Garner; Jean A Smith; Deborah D Demicco; Charles J Schleupner; Rabia A Aldoghaither; Vipul A Savaliya
Journal: Ann Intern Med Date: 2013-02-05 Impact factor: 25.391

Review 10. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors: A Espinel-Ingroff; K Boyle; D J Sheehan
Journal: Mycopathologia Date: 2001 Impact factor: 3.785

7 in total

Reflections on the approach to treatment of a mycologic disaster.

1. Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.

2. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

3. Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum.

4. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

Review 5. Intrathecal amphotericin in the management of coccidioidal meningitis.

6. Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.

7. A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever.

8. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

9. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.

Review 10. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

1. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.

2. CNS Mold Infections.

3. Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States.

4. Mycologic catastrophe.

5. In vitro study of the variable effects of proton pump inhibitors on voriconazole.

6. The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratum.

Review 7. Mold infections of the central nervous system.